28th October 2025
Walker Morris’ Corporate team has advised global healthcare manufacturer Schülke & Mayr on its acquisition of UK-based Redditch Medical, a specialist in cleanroom contamination control for the pharmaceutical and biotech sectors.
Founded in 1889, Schülke & Mayr is a German-headquartered company that manufactures and distributes products for healthcare, industrial hygiene, and personal care. This strategic acquisition strengthens Schülke & Mayr’s life sciences portfolio and reinforces its commitment to seamless cleanroom decontamination for pharmaceutical and biotech customers worldwide.
Corporate Partner Oliver Duke led the Walker Morris team on this transaction, with support from Anna Musk (Associate).
Discussing the deal, Oliver said: “We’re proud to have supported Schülke & Mayr on this strategic acquisition. It is exciting to see Schülke & Mayr expand its existing capabilities with the addition of Redditch Medical’s cleanroom contamination control expertise.”